In vivo interaction of SAF-1 transcription factor with VEGF promoter in MDA-MB-231 cells. In vivo interaction of SAF-1 transcription factor with VEGF promoter.

Slides:



Advertisements
Similar presentations
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Advertisements

PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.
Htr-9 stimulates ICAM-1 gene expression in human ASM cells.
by Bimal K. Ray, Arvind Shakya, James R. Turk, Suneel S
In Vivo Tropism of Hepatitis C Virus Genomic Sequences in Hematopoietic Cells: Influence of Viral Load, Viral Genotype, and Cell Phenotype by Hervé Lerat,
by Hong Hao, Huiling Qi, and Manohar Ratnam
The necdin promoter is a direct target of NSCL‐2.
Pirh2 promotes p73 ubiquitination in vivo.
Comparison of the banding patterns from randomly amplified polymorphic DNA PCR assays of sequential B pseudomallei isolates from each of the cases. Comparison.
AGL15 Interacts in a Sequence-Specific Manner with a Noncanonical CArG Motif Present in the Regulatory Region of AtGA2ox6.(A) Enrichment of the AtGA2ox6.
ATF5 transactivates Egr-1 via the ATF5CON sites in the Egr-1 promoter.
Oligonucleotide aptamer-targeted immune modulation.
Regulation of CSF1 Promoter by the SWI/SNF-like BAF Complex
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Histone deacetylase 1 protein depletion affects general histone acetylation and specific gene expression. Histone deacetylase 1 protein depletion affects.
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
HIS-24 and HPL associate with promoters of antimicrobial genes.
Distinct Pathways for snoRNA and mRNA Termination
A Transient Histone Hyperacetylation Signal Marks Nucleosomes for Remodeling at the PHO8 Promoter In Vivo  Hans Reinke, Philip D. Gregory, Wolfram Hörz 
Gel electrophoresis of measles virus cDNA amplicons (HU2 control measles virus RNA) amplified under optimised reaction conditions. Gel electrophoresis.
Recruitment of SREBP-1c and Dnmts to the Gpam and Scd1 promoters containing SREs, with changes in histone modification. Recruitment of SREBP-1c and Dnmts.
In situ footprinting of the IGRP promoter: primer set C
Genomic structure of LTBP-4 around the 3rd 8-Cys repeat.
In situ footprinting of the IGRP promoter: primer set D
The endogenous IGRP gene is selectively expressed in βTC-3 cells and not in Y1 cells. βTC-3 RNA (50 μg) and Y1 RNA (50 μg) were annealed to labeled oligonucleotide.
Rb Interacts with Histone Deacetylase to Repress Transcription
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
A, scheme of the APC cDNA and the mutant APC cDNAs which were used for reporter gene assays. A, scheme of the APC cDNA and the mutant APC cDNAs which were.
Induction of apoptosis by NS398.
Methylation status of IGFBPL1 in human breast cancer.
CDCP1 is required for invadopodia formation and ECM degradation by human breast cancer cells. CDCP1 is required for invadopodia formation and ECM degradation.
Epigenetic regulation of p16INK4a in human gastric cancer.
CPEB1 protein interacts with the MTDH/AEG-1 mRNA.
CDCP1 colocalizes and interacts with MT1-MMP.
Supplementary Fig. 1 bp E F G H I Hybrid 1 SP2/0 MW P3X (-)
coTCRcys-transduced T cells control tumor growth in vivo.
In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.
Protein expression profile in a dasatinib-resistant cell line.
Competition between FLYWCH1/β-catenin and TCF4/β-catenin complexes for their interaction to Tcf-DNA-binding sites. Competition between FLYWCH1/β-catenin.
SATB2-AS1 repressed Snail transcription depending on SATB2-mediated recruitment of HDAC1. SATB2-AS1 repressed Snail transcription depending on SATB2-mediated.
PELP1 regulates the expression and activities of MMPs in ER-negative cells. PELP1 regulates the expression and activities of MMPs in ER-negative cells.
A, RT-PCR analysis of Eker rat leiomyoma and aged matched normal myometrium. A, RT-PCR analysis of Eker rat leiomyoma and aged matched normal myometrium.
Enhancement of MYC-related HAT complex recruitment to the target genes and histone H4 acetylation by MAPJD. A, interaction of MAPJD with HAT complex containing.
Confirmation of candidates from WT1 binding site screen.
Matriptase-2 inhibited breast tumor development in vivo.
CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.
SAF-1 expression in clinical breast cancer tissues.
Expression pattern of TLR-4 and MyD88 in EOC cells.
EGF-induced HPSE nucleolar localization induces Topo I activity in 231BR3 cells. EGF-induced HPSE nucleolar localization induces Topo I activity in 231BR3.
Comparison of the frequency of nucleotide variation in the mtDNA D-loop region between stomach and other tumor cell lines. Comparison of the frequency.
Interaction of Cdx1 and Cdx2 with the putative Cdx-binding sites of the human DSC2 promoter. Interaction of Cdx1 and Cdx2 with the putative Cdx-binding.
Pirh2 represses p73-dependent transactivation.
Methylation-specific PCR of APC, RASSF1A, and p14ARF genes in bladder tumor and urine DNAs. In the APC gel panel viewed from left to right, the first (TCC34)
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Osteoactivin expression is required for the invasive phenotype of in vivo selected bone metastatic 4T1 breast cancer cells. Osteoactivin expression is.
VEGF165 stimulates migration of HMVECs
CHL-induced apoptosis in HCT116 cells involves the activation of procaspase-8 and procaspase-6, with cleavage of nuclear lamins. CHL-induced apoptosis.
HOXA11-AS acts as a ceRNA for miR-1297.
Methylation targets of TET1 in vitro.
Transfection efficiency and PicoGreen cell survival assays.
Cytokine expression induced by ligated-intestinal-loop assay using RT-PCR. Cytokine expression induced by ligated-intestinal-loop assay using RT-PCR. PCR.
RRP1B interacts with TRIM28 and HP1α at regions associated with H3K9me3 and decreased gene expression. RRP1B interacts with TRIM28 and HP1α at regions.
DDX5 localizes to promoters of DNA replication genes and functions in the loading of RNA polymerase II onto these promoters. DDX5 localizes to promoters.
Expression of anti-versican shRNA decreased breast cancer cell mammosphere and colony formation. Expression of anti-versican shRNA decreased breast cancer.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Loss of NQO1 expression inhibits invasion of NSCLC
WEE1 inhibition followed by TRAIL treatment results in apoptotic cell death in MB231 cells. WEE1 inhibition followed by TRAIL treatment results in apoptotic.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
Treatment with octyl-D-2-HG and octyl-L-2-HG reduces MIR148A expression. Treatment with octyl-D-2-HG and octyl-L-2-HG reduces MIR148A expression. A, Treatment.
MTB1 Interacts with MYC2 and Disrupts MED25-MYC2 Interaction.
Presentation transcript:

In vivo interaction of SAF-1 transcription factor with VEGF promoter in MDA-MB-231 cells. In vivo interaction of SAF-1 transcription factor with VEGF promoter in MDA-MB-231 cells. HMECs (lanes 1–3 and 7–9) and MDA-MB-231 cells (lanes 4–6 and 10–12) were fixed with formaldehyde and immunoprecipitated with SAF-1 Ab or nonspecific IgG (Nonsp. IgG) following the ChIP assay method as described in Materials and Methods. Immunoprecipitated DNAs were used as templates for PCR amplification of human VEGF promoter by using primers encompassing the SAF-1 DNA–binding element or an unrelated element in the VEGF promoter (20). Amplified products were resolved using a 1.5% agarose gel. Alpana Ray et al. Mol Cancer Res 2011;9:1030-1041 ©2011 by American Association for Cancer Research